tiprankstipranks
Trending News
More News >

Charmacy Pharmaceutical Reports Stable Financial Growth in 2024

Story Highlights
Charmacy Pharmaceutical Reports Stable Financial Growth in 2024

Confident Investing Starts Here:

Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.

Charmacy Pharmaceutical Co., Ltd. reported its annual financial results for the year ending December 31, 2024, showing a slight increase in operating revenue to RMB4,435.46 million, up 0.72% from the previous year. The company’s net profit also rose by 3.78% to RMB53.28 million. The board has recommended a final dividend of RMB0.45 per share. These results indicate a stable financial performance, reflecting the company’s steady position in the pharmaceutical market.

More about Charmacy Pharmaceutical Co., Ltd. Class H

Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is primarily focused on the distribution and sale of pharmaceutical products.

YTD Price Performance: -20.61%

Average Trading Volume: 4,888

Technical Sentiment Signal: Buy

Current Market Cap: HK$840.2M

For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App